Literature DB >> 19100773

Clinical malaria vaccine development.

R W Sauerwein1.   

Abstract

Malaria is a major economic and public health problem in mainly sub-Saharan Africa. Globally 300-500 million new infections occur each year with 1-3 million fatal cases in particular young children. The most effective way to reduce disease and death from infectious diseases is to vaccinate susceptible populations. Increasing parasite resistance against available cheap anti-malarial drugs urges the need for development of malaria vaccines.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 19100773     DOI： 10.1016/j.imlet.2008.11.008

Source DB:  PubMed          Journal:  Immunol Lett        ISSN： 0165-2478            Impact factor:   3.685


  6 in total

1.  Cutting Edge: Subunit Booster Vaccination Confers Sterilizing Immunity against Liver-Stage Malaria in Mice Initially Primed with a Weight-Normalized Dose of Radiation-Attenuated Sporozoites.

Authors:  Mitchell N Lefebvre; Lisa L Drewry; Lecia L Pewe; Lisa S Hancox; Arturo Reyes-Sandoval; John T Harty
Journal:  J Immunol       Date:  2021-10-29       Impact factor: 5.422

2.  Why functional pre-erythrocytic and bloodstage malaria vaccines fail: a meta-analysis of fully protective immunizations and novel immunological model.

Authors:  D Lys Guilbride; Pawel Gawlinski; Patrick D L Guilbride
Journal:  PLoS One       Date:  2010-05-19       Impact factor: 3.240

3.  Protection against malaria after immunization by chloroquine prophylaxis and sporozoites is mediated by preerythrocytic immunity.

Authors:  Else M Bijker; Guido J H Bastiaens; Anne C Teirlinck; Geert-Jan van Gemert; Wouter Graumans; Marga van de Vegte-Bolmer; Rianne Siebelink-Stoter; Theo Arens; Karina Teelen; Wiebke Nahrendorf; Edmond J Remarque; Will Roeffen; Annemieke Jansens; Dunja Zimmerman; Martijn Vos; Ben C L van Schaijk; Jorien Wiersma; André J A M van der Ven; Quirijn de Mast; Lisette van Lieshout; Jaco J Verweij; Cornelus C Hermsen; Anja Scholzen; Robert W Sauerwein
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-18       Impact factor: 11.205

4.  Interferon-γ, a valuable surrogate marker of Plasmodium falciparum pre-erythrocytic stages protective immunity.

Authors:  Blanca-Liliana Perlaza; Jean-Pierre Sauzet; Karima Brahimi; Lbachir BenMohamed; Pierre Druilhe
Journal:  Malar J       Date:  2011-02-08       Impact factor: 2.979

5.  Expeditious recruitment of circulating memory CD8 T cells to the liver facilitates control of malaria.

Authors:  Mitchell N Lefebvre; Fionna A Surette; Scott M Anthony; Rahul Vijay; Isaac J Jensen; Lecia L Pewe; Lisa S Hancox; Natalija Van Braeckel-Budimir; Stephanie van de Wall; Stina L Urban; Madison R Mix; Samarchith P Kurup; Vladimir P Badovinac; Noah S Butler; John T Harty
Journal:  Cell Rep       Date:  2021-11-02       Impact factor: 9.423

6.  Memory B-cell and antibody responses induced by Plasmodium falciparum sporozoite immunization.

Authors:  Wiebke Nahrendorf; Anja Scholzen; Else M Bijker; Anne C Teirlinck; Guido J H Bastiaens; Remko Schats; Cornelus C Hermsen; Leo G Visser; Jean Langhorne; Robert W Sauerwein
Journal:  J Infect Dis       Date:  2014-06-25       Impact factor: 5.226
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.